Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis

Fig. 4

Meta-analysis of safety of artemisinin combination therapy administration (PR: DerSimonian-larid random-effects untransformed proportion). Abbreviations: - C.I.: confidence interval, n: events, N: total in the intention-to-treat analysis, CDA: Chlorproguanil-dapsone-artesunate, AL: Artemether–Lumefantrine, DP: dihydroartemisinin-piperaquine, ASAQ: Artesunate–Amodiaquine, PA: pyronaridine-artesunate, ASSMP: Artesunate-Sulphamethoxypyrazine-Pyrimethamine

Back to article page
\